BL 1060

Drug Profile

BL 1060

Alternative Names: BL-1060

Latest Information Update: 09 May 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Galmed International
  • Class Small molecules
  • Mechanism of Action Cholesterol inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Liver disorders; Non-alcoholic steatohepatitis

Most Recent Events

  • 13 Apr 2005 Preclinical trials in Liver disorders in Israel (PO)
  • 13 Apr 2005 Preclinical trials in Non-alcoholic steatohepatitis in Israel (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top